-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, C/OipGqpq8pH+07MUMdt2HPr1Vr+qdwr8PLwJss8qKhP6f5iUSE8V9x+bfoZ+wqm hCJTV9HnIauaOML5ZRxxYg== 0001029869-97-000157.txt : 19970222 0001029869-97-000157.hdr.sgml : 19970222 ACCESSION NUMBER: 0001029869-97-000157 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19970214 SROS: NONE GROUP MEMBERS: ALAN G. WALTON GROUP MEMBERS: CORNELIUS T. RYAN GROUP MEMBERS: EDMUND M. OLIVIER GROUP MEMBERS: OBP MANAGEMENT (BERMUDA) LIMITED PARTNERSHIP GROUP MEMBERS: OBP MANAGEMENT (BERMUDA) LTD. GROUP MEMBERS: OBP MANAGEMENT L.P. GROUP MEMBERS: OXFORD BIOSCIENCE PARTNERS (ADJUNCT) L.P. GROUP MEMBERS: OXFORD BIOSCIENCE PARTNERS (BERMUDA) LP GROUP MEMBERS: OXFORD BIOSCIENCE PARTNERS L P ET AL SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: COLLABORATIVE CLINICAL RESEARCH INC CENTRAL INDEX KEY: 0000886530 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 341685364 STATE OF INCORPORATION: OH FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-48311 FILM NUMBER: 97533048 BUSINESS ADDRESS: STREET 1: 20600 CHAGRIN BLVD STREET 2: STE 1050 CITY: CLEVELAND STATE: OH ZIP: 44122 BUSINESS PHONE: 2164919930 MAIL ADDRESS: STREET 1: 20600 CHAGRIN BLVD STREET 2: STE 1050 CITY: CLEVELAND STATE: OH ZIP: 44122 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: OXFORD BIOSCIENCE PARTNERS L P ET AL CENTRAL INDEX KEY: 0000938806 STANDARD INDUSTRIAL CLASSIFICATION: [] IRS NUMBER: 061346307 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 315 POST ROAD WEST CITY: WESTPORT STATE: CT ZIP: 06880 BUSINESS PHONE: 2033413300 MAIL ADDRESS: STREET 1: 315 POST ROAD WEST CITY: WESTPORT STATE: CT ZIP: 06880 SC 13G 1 -------------------------- OMB APPROVAL ----------------------- OMB Number: 3235-0145 Expires: October 31, 1997 Estimated average burden hours per response...14.90 -------------------------- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. _______________)* Collaborative Clinical Research, Inc. (Name of Issuer) Common Stock, $.01 par value (Title of Class of Securities) 194190 10 4 (CUSIP Number) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 444903108 13G Page 2 of 19 Pages - -------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSON S.S. or I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Oxford Bioscience Partners L.P. - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) |_| (b) |_| - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware Limited Partnership - -------------------------------------------------------------------------------- 5 SOLE VOTING POWER 0 Shares NUMBER OF ---------------------------------------------------- SHARES 6 SHARED VOTING POWER BENEFICIALLY 655,752 Shares OWNED BY EACH ---------------------------------------------------- REPORTING 7 SOLE DISPOSITIVE POWER PERSON 0 Shares WITH ---------------------------------------------------- 8 SHARED DISPOSITIVE POWER 655,752 Shares - -------------------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 655,752 Shares - -------------------------------------------------------------------------------- CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* - -------------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 10.4% - -------------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON* PN - -------------------------------------------------------------------------------- CUSIP No. 444903108 13G Page 3 of 19 Pages - -------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSON S.S. or I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Oxford Bioscience Partners (Adjunct) L.P. - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) |_| (b) |_| - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware Limited Partnership - -------------------------------------------------------------------------------- 5 SOLE VOTING POWER 0 Shares NUMBER OF ---------------------------------------------------- SHARES 6 SHARED VOTING POWER BENEFICIALLY 655,752 Shares OWNED BY EACH ---------------------------------------------------- REPORTING 7 SOLE DISPOSITIVE POWER PERSON 0 Shares WITH ---------------------------------------------------- 8 SHARED DISPOSITIVE POWER 655,752 Shares - -------------------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 655,752 Shares - -------------------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* - -------------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 10.4% - -------------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON* PN - -------------------------------------------------------------------------------- CUSIP No. 444903108 13G Page 4 of 19 Pages - -------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSON S.S. or I.R.S. IDENTIFICATION NO. OF ABOVE PERSON OBP Management L.P. - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) |_| (b) |_| - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware Limited Partnership - -------------------------------------------------------------------------------- 5 SOLE VOTING POWER 0 Shares NUMBER OF ---------------------------------------------------- SHARES 6 SHARED VOTING POWER BENEFICIALLY 655,752 Shares OWNED BY EACH ---------------------------------------------------- REPORTING 7 SOLE DISPOSITIVE POWER PERSON 0 Shares WITH ---------------------------------------------------- 8 SHARED DISPOSITIVE POWER 655,752 Shares - -------------------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 655,752 Shares - -------------------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* - -------------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 10.4% - -------------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON* PN - -------------------------------------------------------------------------------- CUSIP No. 444903108 13G Page 5 of 19 Pages - -------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSON S.S. or I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Oxford Bioscience Partners (Bermuda) Limited Partnership - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) |_| (b) |_| - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION Bermuda Limited Partnership - -------------------------------------------------------------------------------- 5 SOLE VOTING POWER 0 Shares NUMBER OF ---------------------------------------------------- SHARES 6 SHARED VOTING POWER BENEFICIALLY 655,752 Shares OWNED BY EACH ---------------------------------------------------- REPORTING 7 SOLE DISPOSITIVE POWER PERSON 0 Shares WITH ---------------------------------------------------- 8 SHARED DISPOSITIVE POWER 655,752 Shares - -------------------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 655,752 Shares - -------------------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* - -------------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 10.4% - -------------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON* PN - -------------------------------------------------------------------------------- CUSIP No. 444903108 13G Page 6 of 19 Pages - -------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSON S.S. or I.R.S. IDENTIFICATION NO. OF ABOVE PERSON OBP Management (Bermuda) Limited Partnership - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) |_| (b) |_| - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION Bermuda Limited Partnership - -------------------------------------------------------------------------------- 5 SOLE VOTING POWER 0 Shares NUMBER OF ---------------------------------------------------- SHARES 6 SHARED VOTING POWER BENEFICIALLY 655,752 Shares OWNED BY EACH ---------------------------------------------------- REPORTING 7 SOLE DISPOSITIVE POWER PERSON 0 Shares WITH ---------------------------------------------------- 8 SHARED DISPOSITIVE POWER 655,752 Shares - -------------------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 655,752 Shares - -------------------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* - -------------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 10.4% - -------------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON* PN - -------------------------------------------------------------------------------- CUSIP No. 444903108 13G Page 7 of 19 Pages - -------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSON S.S. or I.R.S. IDENTIFICATION NO. OF ABOVE PERSON OBP Management (Bermuda) Ltd. - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) |_| (b) |_| - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION Bermuda Corporation - -------------------------------------------------------------------------------- 5 SOLE VOTING POWER 0 Shares NUMBER OF ---------------------------------------------------- SHARES 6 SHARED VOTING POWER BENEFICIALLY 113,378 Shares OWNED BY EACH ---------------------------------------------------- REPORTING 7 SOLE DISPOSITIVE POWER PERSON 0 Shares WITH ---------------------------------------------------- 8 SHARED DISPOSITIVE POWER 113,378 Shares - -------------------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 113,378 Shares - -------------------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* - -------------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 1.8% - -------------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON* CO - -------------------------------------------------------------------------------- CUSIP No. 444903108 13G Page 8 of 19 Pages - -------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSON S.S. or I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Edmund M. Olivier - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) |_| (b) |_| - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION United States - -------------------------------------------------------------------------------- 5 SOLE VOTING POWER 0 Shares NUMBER OF ---------------------------------------------------- SHARES 6 SHARED VOTING POWER BENEFICIALLY 655,752 Shares OWNED BY EACH ---------------------------------------------------- REPORTING 7 SOLE DISPOSITIVE POWER PERSON 0 Shares WITH ---------------------------------------------------- 8 SHARED DISPOSITIVE POWER 655,752 Shares - -------------------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 655,752 Shares - -------------------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* - -------------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 10.4% - -------------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON* IN - -------------------------------------------------------------------------------- CUSIP No. 444903108 13G Page 9 of 19 Pages - -------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSON S.S. or I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Cornelius T. Ryan - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) |_| (b) |_| - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION United States - -------------------------------------------------------------------------------- 5 SOLE VOTING POWER 0 Shares NUMBER OF ---------------------------------------------------- SHARES 6 SHARED VOTING POWER BENEFICIALLY 655,752 Shares OWNED BY EACH ---------------------------------------------------- REPORTING 7 SOLE DISPOSITIVE POWER PERSON 0 Shares WITH ---------------------------------------------------- 8 SHARED DISPOSITIVE POWER 655,752 Shares - -------------------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 655,752 Shares - -------------------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* - -------------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 10.4% - -------------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON* IN - -------------------------------------------------------------------------------- CUSIP No. 444903108 13G Page 10 of 19 Pages - -------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSON S.S. or I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Alan G. Walton - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) |_| (b) |_| - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION United States - -------------------------------------------------------------------------------- 5 SOLE VOTING POWER 0 Shares NUMBER OF ---------------------------------------------------- SHARES 6 SHARED VOTING POWER BENEFICIALLY 655,752 Shares OWNED BY EACH ---------------------------------------------------- REPORTING 7 SOLE DISPOSITIVE POWER PERSON 0 Shares WITH ---------------------------------------------------- 8 SHARED DISPOSITIVE POWER 655,752 Shares - -------------------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 655,752 Shares - -------------------------------------------------------------------------------- 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* - -------------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 10.4% - -------------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON* IN - -------------------------------------------------------------------------------- NOTE: This Statement on Schedule 13G is being filed on behalf of (i) Oxford Bioscience Partners L.P., a Delaware limited partnership; (ii) Oxford Bioscience Partners (Adjunct) L.P., a Delaware limited partnership; (iii) OBP Management L.P., a Delaware limited partnership; (iv) Oxford Bioscience Partners (Bermuda) Limited Partnership, a Bermuda limited partnership; (v) OBP Management (Bermuda) Limited Partnership, a Bermuda limited partnership; (vi) OBP Management (Bermuda) Ltd., a Bermuda corporation; (vii) Edmund M. Olivier; (viii) Cornelius T. Ryan; and (ix) Alan G. Walton. Item 1(a). Name of Issuer: Collaborative Clinical Research, Inc. Item 1(b). Address of Issuer's Principal Executive Offices: 20600 Chagrin Blvd., Cleveland, Ohio 44122 Item 2(a) Item 2(b) Item 2(c) --------- --------- --------- Citizenship or Place Name of Person Filing Address of Organization --------------------- ------- --------------- Oxford Bioscience Partners Oxford Bioscience Partners Delaware L.P. ("OBP") 315 Post Road West Westport, CT 06880 Oxford Bioscience Partners Oxford Bioscience Partners Delaware (Adjunct) L.P. ("OBP 315 Post Road West Adjunct") Westport, CT 06880 OBP Management L.P. ("OBP Oxford Bioscience Partners Delaware Management"), the 315 Post Road West general partner of OBP Westport, CT 06880 and OBP Adjunct Oxford Bioscience Partners Richmond House Bermuda (Bermuda) Limited Par-la-Ville Road Partnership ("OBP Hamilton, Bermuda Bermuda") OBP Management (Bermuda) Richmond House Bermuda L.P. ("OBP Management Par-la-Ville Road Bermuda"), the general Hamilton, Bermuda partner of OBP Bermuda OBP Management Bermuda Ltd. Richmond House Bermuda ("Bermuda Corp.") a Par-la-Ville Road general partner of OBP Hamilton, Bermuda Management Bermuda Edmund M. Olivier, a general Oxford Bioscience Partners United States partner of OBP 650 Town Center Drive Management and OBP Costa Mesa, California Management Bermuda 92626 Cornelius T. Ryan, a general Oxford Bioscience Partners United States partner of OBP 315 Post Road West Management and OBP Westport, CT 06880 Management Bermuda Alan G. Walton, a general Oxford Bioscience Partners United States partner of OBP 315 Post Road West Management and OBP Westport, CT 06880 Management Bermuda Page 11 of Pages 19 Item 2(d). Title of Class of Securities: Common Stock, $.01 par value. Item 2(e). CUSIP Number: 194190 10 4 Item 3. If this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b), check whether the person filing is a: (a) |_| Broker or Dealer registered under Section 15 of the Securities Exchange Act of 1934 (the "Act"). (b) |_| Bank as defined in Section 3(a)(6) of the Act. (c) |_| Insurance Company as defined in Section 3(a)(19) of the Act. (d) |_| Investment Company registered under Section 8 of the Investment Company Act of 1940. (e) |_| Investment Adviser registered under Section 203 of the Investment Advisers Act of 1940. (f) |_| Employee Benefit Plan, Pension Fund which is subject to the provisions of the Employee Retirement Income Security Act of 1974 or Endowment Fund; see Rule 13d-1(b)(1)(ii)(F) of the Act. (g) |_| Parent Holding Company, in accordance with Rule 13d-1(b)(ii)(G) of the Act. (h) |_| Group, in accordance with Rule 13d-1(b)(1)(ii)(H) of the Act. None of the above. Item 4. Ownership. (a) Amount Beneficially Owned: As of December 31, 1996, each of the following is the owner of record of the number of shares of Common Stock set forth next to his, her or its name: OBP: 408,690 Shares OBP Adjunct: 130,517 Shares OBP Management: 0 Shares OBP Bermuda: 113,378 Shares OBP Management Bermuda: 0 Shares Bermuda Corp.: 0 Shares Mr. Olivier: 0 Shares Mr. Ryan: 0 Shares Mr. Walton: 0 Shares By virtue of their relationship as affiliated limited partnerships, whose sole general partners share individual general partners, OBP, OBP Adjunct and OBP Bermuda may be deemed to share voting power and the power to direct the disposition of the shares of Common Stock which each partnership owns of record. Additionally, OBP Management owns presently exerciseable options to purchase an aggregate of 3,167 shares of Common Stock. Messrs. Ryan, Walton and Olivier are general partners of both OBP Management, the general partner of OBP and OBP Adjunct, and OBP Bermuda Management, the general Page 12 of Pages 19 partner OBP Bermuda. Therefore, each of Messrs. Ryan, Walton and Olivier may be deemed to own beneficially the shares held by each of OBP, OBP Adjunct and OBP Bermuda. Bermuda Corp. is deemed to beneficially own the shares owned by OBP Bermuda, as it is solely a general partner of OBP Bermuda Management, the general partner of OBP Bermuda. (b) Percent of Class: OBP: 10.4% OBP Adjunct: 10.4% OBP Management: 10.4% OBP Bermuda: 10.4% OBP Management Bermuda: 10.4% Bermuda Corp.: 1.8% Mr. Olivier: 10.4% Mr. Ryan: 10.4% Mr. Walton: 10.4% The foregoing percentages are calculated based on the 6,307,914 shares of Common Stock reported to be outstanding in the Quarterly Report on Form 10-Q of Collaborative Clinical Research, Inc. for the quarter ended September 30, 1996. (c) Number of shares as to which such person has: (i) sole power to vote or to direct the vote: OBP: 0 Shares OBP Adjunct: 0 Shares OBP Management: 0 Shares OBP Bermuda: 0 Shares OBP Management Bermuda: 0 Shares Bermuda Corp.: 0 Shares Mr. Olivier: 0 Shares Mr. Ryan: 0 Shares Mr. Walton: 0 Shares (ii) shared power to vote or to direct the vote: OBP: 655,752 Shares OBP Adjunct: 655,752 Shares OBP Management: 655,752 Shares OBP Bermuda: 655,752 Shares OBP Management Bermuda: 655,752 Shares Bermuda Corp.: 113,378 Shares Mr. Olivier: 655,752 Shares Mr. Ryan: 655,752 Shares Mr. Walton: 655,752 Shares Page 13 of Pages 19 (iii) sole power to dispose or to direct the disposition of: OBP: 0 Shares OBP Adjunct: 0 Shares OBP Management: 0 Shares OBP Bermuda: 0 Shares OBP Management Bermuda: 0 Shares Bermuda Corp.: 0 Shares Mr. Olivier: 0 Shares Mr. Ryan: 0 Shares Mr. Walton: 0 Shares (iv) shared power to dispose or to direct the disposition of: OBP: 655,752 Shares OBP Adjunct: 655,752 Shares OBP Management: 655,752 Shares OBP Bermuda: 655,752 Shares OBP Management Bermuda: 655,752 Shares Bermuda Corp.: 113,378 Shares Mr. Olivier: 655,752 Shares Mr. Ryan: 655,752 Shares Mr. Walton: 655,752 Shares Each of OBP, OBP Adjunct, OBP Management, OBP Bermuda, OBP Management Bermuda, Bermuda Corp., Mr. Olivier, Mr. Ryan and Mr. Walton expressly disclaims beneficial ownership of any shares of Common Stock of Collaborative Clinical Research, Inc., except any shares held directly of record. Item 5. Ownership of Five Percent or Less of a Class. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following: |_| Item 6. Ownership of More than Five Percent on Behalf of Another Person. Not applicable. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company. Not applicable. Item 8. Identification and Classification of Members of the Group. Not applicable. OBP, OBP Adjunct, OBP Management, OBP Bermuda, OBP Management Bermuda, Bermuda Corp., Mr. Olivier, Mr. Ryan and Mr. Walton expressly disclaim membership in a "group" as defined in Rule 13d-1(b)(ii)(H). Item 9. Notice of Dissolution of Group. Not applicable. Page 14 of Pages 19 Item 10. Certification. Not applicable. This statement on Schedule 13G is not filed pursuant to Rule 13d-1(b). Attached as Exhibit 1 hereto is a Joint Filing Agreement executed by each of the filing persons pursuant to Rule 13d-1(f) under Section 13(d) of the Act. Page 15 of Pages 19 Signature After reasonable inquiry and to the best of his, her or its knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct. We also hereby agree to file this statement jointly pursuant to the agreement set forth as Exhibit 1 hereto. Dated: February 12, 1997 OXFORD BIOSCIENCE PARTNERS L.P. By: OBP Management L.P., its general partner By: /s/ Alan G. Walton ------------------------------------ Alan G. Walton General Partner OXFORD BIOSCIENCE PARTNERS (ADJUNCT) L.P. By: OBP Management L.P., its general partner By: /s/ Alan G. Walton ------------------------------------ Alan G. Walton General Partner OXFORD BIOSCIENCE PARTNERS (BERMUDA) LIMITED PARTNERSHIP By: OBP Management (Bermuda) Limited Partnership, its general partner By: /s/ Alan G. Walton ------------------------------------ Alan G. Walton General Partner OBP MANAGEMENT L.P. By: /s/ Alan G. Walton ------------------------------------ Alan G. Walton General Partner OBP MANAGEMENT (BERMUDA) LIMITED PARTNERSHIP By: /s/ Alan G. Walton ------------------------------------ Alan G. Walton General Partner Page 16 of Pages 19 OBP MANAGEMENT (BERMUDA) LTD. By: /s/ Alan G. Walton ------------------------------------ Title: General Partner /s/ Cornelius T. Ryan ------------------------------------ Cornelius T. Ryan /s/ Alan G. Walton ------------------------------------ Alan G. Walton /s/ Edmund M. Olivier ------------------------------------ Edmund M. Olivier Page 17 of Pages 19 Exhibit 1 AGREEMENT Pursuant to Rule 13d-1(f) (1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13G need be filed with respect to the ownership by each of the undersigned of shares of Common Stock of Collaborative Clinical Research, Inc. This Agreement may be executed in any number of counterparts, each of which shall be deemed an original. EXECUTED this 12th day of February, 1997. OXFORD BIOSCIENCE PARTNERS L.P. By: OBP Management L.P., its general partner By: /s/ Alan G. Walton ------------------------------------ Alan G. Walton General Partner OXFORD BIOSCIENCE PARTNERS (ADJUNCT) L.P. By: OBP Management L.P., its general partner By: /s/ Alan G. Walton ------------------------------------ Alan G. Walton General Partner OXFORD BIOSCIENCE PARTNERS (BERMUDA) LIMITED PARTNERSHIP By: OBP Management (Bermuda) Limited Partnership, its general partner By: /s/ Alan G. Walton ------------------------------------ Alan G. Walton General Partner OBP MANAGEMENT L.P. By: /s/ Alan G. Walton ------------------------------------ Alan G. Walton General Partner Page 18 of Pages 19 OBP MANAGEMENT (BERMUDA) LIMITED PARTNERSHIP By: /s/ Alan G. Walton ------------------------------------ Alan G. Walton General Partner OBP MANAGEMENT (BERMUDA) LTD. By: /s/ Alan G. Walton ------------------------------------ Title: General Partner /s/ Cornelius T. Ryan ------------------------------------ Cornelius T. Ryan /s/ Alan G. Walton ------------------------------------ Alan G. Walton /s/ Edmund M. Olivier ------------------------------------ Edmund M. Olivier Page 19 of Pages 19 -----END PRIVACY-ENHANCED MESSAGE-----